[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR2788982B1 - Compositions pharmaceutiques contenant de la nicotine et leur application dans le sevrage tabagique - Google Patents

Compositions pharmaceutiques contenant de la nicotine et leur application dans le sevrage tabagique

Info

Publication number
FR2788982B1
FR2788982B1 FR9901144A FR9901144A FR2788982B1 FR 2788982 B1 FR2788982 B1 FR 2788982B1 FR 9901144 A FR9901144 A FR 9901144A FR 9901144 A FR9901144 A FR 9901144A FR 2788982 B1 FR2788982 B1 FR 2788982B1
Authority
FR
France
Prior art keywords
application
pharmaceutical compositions
compositions containing
containing nicotine
smoking withdrawal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9901144A
Other languages
English (en)
Other versions
FR2788982A1 (fr
Inventor
Dominique Caille
Samir Jegham
Bernard Scatton
Pascal George
Branimir Zivkovic
Pascale Robineau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synthelabo SA
Original Assignee
Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9901144A priority Critical patent/FR2788982B1/fr
Application filed by Synthelabo SA filed Critical Synthelabo SA
Priority to EP00901660A priority patent/EP1150715A1/fr
Priority to AU22988/00A priority patent/AU2298800A/en
Priority to PCT/FR2000/000193 priority patent/WO2000045846A1/fr
Priority to HU0201279A priority patent/HUP0201279A2/hu
Priority to JP2000596965A priority patent/JP2002536342A/ja
Priority to CA002361437A priority patent/CA2361437A1/fr
Priority to ARP000100404A priority patent/AR028983A1/es
Publication of FR2788982A1 publication Critical patent/FR2788982A1/fr
Application granted granted Critical
Publication of FR2788982B1 publication Critical patent/FR2788982B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Addiction (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
FR9901144A 1999-02-02 1999-02-02 Compositions pharmaceutiques contenant de la nicotine et leur application dans le sevrage tabagique Expired - Fee Related FR2788982B1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR9901144A FR2788982B1 (fr) 1999-02-02 1999-02-02 Compositions pharmaceutiques contenant de la nicotine et leur application dans le sevrage tabagique
AU22988/00A AU2298800A (en) 1999-02-02 2000-01-28 Pharmaceutical compositions containing nicotine or a ligand of nicotine receptors and a monamine oxydase inhibitor and their use for treating tobacco withdrawalsymptoms
PCT/FR2000/000193 WO2000045846A1 (fr) 1999-02-02 2000-01-28 Compositions pharmaceutiques contenant de la nicotine ou un ligand des recepteurs nicotiniques et un inhibiteur de la monamine oxydase et leur application dans le sevrage tabagique
HU0201279A HUP0201279A2 (en) 1999-02-02 2000-01-28 Pharmaceutical compositions containing nicotine or a ligand of nicotine receptors and a monamine oxydase inhibitor and their use for treating tobacco withdrawal symptoms
EP00901660A EP1150715A1 (fr) 1999-02-02 2000-01-28 Compositions pharmaceutiques contenant de la nicotine ou un ligand des recepteurs nicotiniques et un inhibiteur de la monoamine oxydase
JP2000596965A JP2002536342A (ja) 1999-02-02 2000-01-28 ニコチン又はニコチンレセプターのリガンドとモノアミンオキシダーゼ阻害剤を含む医薬組成物、ならびにタバコ離脱症状を治療するためのそれらの使用
CA002361437A CA2361437A1 (fr) 1999-02-02 2000-01-28 Compositions pharmaceutiques contenant de la nicotine ou un ligand des recepteurs nicotiniques et un inhibiteur de la monamine oxydase et leur application dans le sevrage tabagique
ARP000100404A AR028983A1 (es) 1999-02-02 2000-01-31 Composiciones farmaceuticas que contienen nicotina o un ligando de los receptores nicotinicos y un inhibidor de la monoamina oxidasa y su aplicacion en la abstinencia de tabaco

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9901144A FR2788982B1 (fr) 1999-02-02 1999-02-02 Compositions pharmaceutiques contenant de la nicotine et leur application dans le sevrage tabagique

Publications (2)

Publication Number Publication Date
FR2788982A1 FR2788982A1 (fr) 2000-08-04
FR2788982B1 true FR2788982B1 (fr) 2002-08-02

Family

ID=9541474

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9901144A Expired - Fee Related FR2788982B1 (fr) 1999-02-02 1999-02-02 Compositions pharmaceutiques contenant de la nicotine et leur application dans le sevrage tabagique

Country Status (8)

Country Link
EP (1) EP1150715A1 (fr)
JP (1) JP2002536342A (fr)
AR (1) AR028983A1 (fr)
AU (1) AU2298800A (fr)
CA (1) CA2361437A1 (fr)
FR (1) FR2788982B1 (fr)
HU (1) HUP0201279A2 (fr)
WO (1) WO2000045846A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7900637B2 (en) 2001-06-25 2011-03-08 Niconovum Ab Device and method for the administration of a substance
US8741348B2 (en) 2002-12-20 2014-06-03 Niconovum Ab Physically and chemically stable nicotine-containing particulate material
US9402809B2 (en) 2006-03-16 2016-08-02 Niconovum Usa, Inc. Snuff composition

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ME00459B (me) * 1997-12-31 2011-10-10 Pfizer Prod Inc Aril fuzirana azapoliciklična jedinjenja
US6605610B1 (en) * 1997-12-31 2003-08-12 Pfizer Inc Aryl fused azapolycyclic compounds
EP1133494B1 (fr) 1998-11-27 2004-02-18 Neurosearch A/S Derives de 8-azabicyclo 3.2.1]oct-2-ene et de 8-azabicyclo 3.2.1]octane
IL137937A0 (en) * 1999-08-27 2001-10-31 Pfizer Prod Inc A pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal
ATE334979T1 (de) * 2000-10-13 2006-08-15 Neurosearch As Behandlung affektiver störungen durch kombinierte wirkung eines nikotinischen rezeptoragonisten und einer monoaminergischen substanz
BR0208992A (pt) * 2001-04-20 2004-04-27 Pfizer Prod Inc Processo para a preparação de indenos 1,3-substituìdos e compostos azapolicìclicos fundidos com arila
CA2463987C (fr) 2001-11-05 2011-03-08 Seth Lederman Compositions et methodes permettant d'augmenter l'observance therapeutique au moyen d'inhibiteurs de l'aldehyde deshydrogenase et traitement de l'alcoolisme
KR20040099447A (ko) 2002-04-18 2004-11-26 아스트라제네카 아베 푸릴 화합물
WO2003087104A1 (fr) 2002-04-18 2003-10-23 Astrazeneca Ab Composes heterocycliques
KR20040099448A (ko) * 2002-04-18 2004-11-26 아스트라제네카 아베 티에닐 화합물
WO2004019943A1 (fr) 2002-08-30 2004-03-11 Memory Pharmaceuticals Corporation Derives d'anabaseine utiles pour le traitement de maladies neurodegeneratives
PL210065B1 (pl) 2002-09-25 2011-11-30 Memory Pharm Corp Związki indazole, benzotiazole i benzoizotiazole, kompozycje farmaceutyczne je zawierające oraz zastosowanie związków
IL155666A (en) * 2003-04-29 2013-12-31 Neurim Pharma 1991 Insomnia treatment
DE10338174A1 (de) * 2003-08-20 2005-03-24 Lts Lohmann Therapie-Systeme Ag Transdermale Arzneimittelzubereitungen mit Wirkstoffkombinationen zur Behandlung der Parkinson-Krankheit
KR20060120694A (ko) 2003-12-22 2006-11-27 메모리 파마슈티칼스 코포레이션 인돌, 1ｈ-인다졸, 1,2-벤즈이속사졸 및1,2-벤즈이소티아졸, 및 이들의 제법 및 용도
CN103724343A (zh) 2004-03-25 2014-04-16 记忆药物公司 吲唑、苯并噻唑、苯并异噻唑、苯并异噁唑及其制备和用途
DE602005024677D1 (de) 2004-04-22 2010-12-23 Memory Pharm Corp Indole, 1h-indazole, 1,2-benzisoxazole, 1,2-benzoisothiazole, deren herstellung und verwendungen
RU2386633C2 (ru) 2004-05-07 2010-04-20 Мемори Фармасьютиклз Корпорейшн 1h-индазолы, бензотиазолы, 1, 2-бензоизоксазолы, 1, 2-бензоизотиазолы и хромоны и их получение и применения
US7459469B2 (en) 2004-11-10 2008-12-02 Targacept, Inc. Hydroxybenzoate salts of metanicotine compounds
PL1828179T3 (pl) 2004-12-22 2010-08-31 Memory Pharm Corp Ligandy dla receptorów nikotynowych alfa-7 przeciwko chorobom związanym z OUN
US8106066B2 (en) 2005-09-23 2012-01-31 Memory Pharmaceuticals Corporation Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof
WO2007100430A2 (fr) * 2006-01-27 2007-09-07 Yale University Analogues de cystisine et d'acétylcholine et procédés de traitement des troubles de l'humeur
TWI389889B (zh) 2006-05-09 2013-03-21 Targacept Inc （２ｓ）-（４ｅ）-ｎ-甲基-５-〔３-（５-異丙氧基吡啶）基〕-４-戊烯-２-胺之新穎多晶型
EP2021325A2 (fr) 2006-05-09 2009-02-11 AstraZeneca AB Formes de sel de (2s)-(4e)-n-méthyl-5-[3-(5-isopropoxypyridin)yl]-4-penten-2-amine
EP2112923A1 (fr) * 2007-01-22 2009-11-04 Targacept Inc. Administration intranasale, buccale ou sublinguale d'analogues de métanicotine
WO2009058120A1 (fr) * 2007-11-02 2009-05-07 Sri International Modulateurs des récepteurs nicotiniques de l'acétylcholine
US8697722B2 (en) * 2007-11-02 2014-04-15 Sri International Nicotinic acetylcholine receptor modulators
EP2523562B1 (fr) 2010-01-11 2019-01-02 Astraea Therapeutics, LLC Modulateurs du récepteur nicotinique de l'acétylcholine
US8703802B2 (en) 2010-05-20 2014-04-22 Targacept, Inc. Process for the preparation of aryl substituted olefinic amines
CA2809966C (fr) 2010-09-01 2019-01-08 Tonix Pharmaceuticals, Inc. Traitement contre la cocainomanie
US10653639B2 (en) * 2016-05-16 2020-05-19 Cv Sciences, Inc. Pharmaceutical formulations containing cannabidiol and nicotine for treating smokeless tobacco addiction

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2446895A (en) * 1994-04-22 1995-11-16 Assistance Publique - Hopitaux De Paris Use of mao-a inhibitors for the manufacture of a medicament in the treatment of tobacco withdrawal symptoms in smokers
US5803081A (en) * 1996-06-28 1998-09-08 Regent Court Technologies Tobacco and related products

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7900637B2 (en) 2001-06-25 2011-03-08 Niconovum Ab Device and method for the administration of a substance
US8741348B2 (en) 2002-12-20 2014-06-03 Niconovum Ab Physically and chemically stable nicotine-containing particulate material
US9402809B2 (en) 2006-03-16 2016-08-02 Niconovum Usa, Inc. Snuff composition

Also Published As

Publication number Publication date
HUP0201279A2 (en) 2002-09-28
AU2298800A (en) 2000-08-25
CA2361437A1 (fr) 2000-08-10
EP1150715A1 (fr) 2001-11-07
WO2000045846A1 (fr) 2000-08-10
JP2002536342A (ja) 2002-10-29
FR2788982A1 (fr) 2000-08-04
AR028983A1 (es) 2003-06-04

Similar Documents

Publication Publication Date Title
FR2788982B1 (fr) Compositions pharmaceutiques contenant de la nicotine et leur application dans le sevrage tabagique
MA26443A1 (fr) Aralkyl- et aralkylidene-lactames et -imides heterocycliques, procedes pour leur preparation et compositions pharmaceutiques les contenant
FR2805818B1 (fr) Derives d'azetidine, leur preparation et les compositions pharmaceutiques les contenant
MA24193A1 (fr) Procedes pour la preparation de conjugue peg-ifn alpha physiologiquement actif, et pour la preparation de compositions pharmaceutiques le contenant et leur utilisation
MA26714A1 (fr) Composes nouveaux modulateurs de chimiokine ccr5 et compositions pharmaceutiques les contenant
FR2807038B1 (fr) Nouveaux derives d'indolin-2-one, leur preparation et les compositions pharmaceutiques les contenant
FR2732967B1 (fr) 1-phenylpyrazole-3-carboxamides substitues, actifs sur la neurotensine, leur preparation, les compositions pharmaceutiques en contenant
ATE263558T1 (de) Lipasehemmer und chitosan enthaltende pharmazeutische zusammensetzungen
EP1231864A4 (fr) Catheters pour l'administration de medicaments se fixant aux tissus et son procede d'utilisation
FR2780057B1 (fr) Phenoxypropanolamines, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2816938B1 (fr) Derives de 3-aroylindole, leur procede de preparation et les compositions pharmaceutiques en contenant
MA26537A1 (fr) Derives de 2-aminopyridine nouveaux et compositions pharmaceutiques les contenant.
FR2811992B1 (fr) Melanges de polysaccharides derives d'heparine, leur preparation et les compositions pharmaceutiques les contenant
MA26882A1 (fr) COMPOSITIONS PHARMACEUTIQUES D'INHIBITEURS ET GLYCOGèNE-PHOSPHORYLASE
FR2792836B3 (fr) Composition pharmaceutique sous forme unitaire contenant de l'aspirine et de l'hydrogenosulfate de clopidogrel
DE60037816D1 (de) Pharmazeutische formulierung enthaltend megalatran und dessen pro-pharmaka
FR2751334B1 (fr) Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant
ATE288766T1 (de) Pharmazeutische zusammensetzungen zur oralen und topischen verabreichung
FR2751969B1 (fr) Composes activateurs du canal cftr, et compositions pharmaceutiques les contenant
FR2796070B1 (fr) Derives de benzodiazepines utilisables dans le traitement de dyslipidemies, de l'atherosclerose et du diabete, compositions pharmaceutiques les contenant et procedes de preparation
NO20013205D0 (no) Farmasöytiske formuleringer i hydroksypropylmetylcellulosekapsler
HUP9802897A3 (en) Optically active pyridyl-4h-1,2,4-oxadiazine derivatives, the use thereof in the treatment of vascular diseases and pharmaceutical composition containing the compound as active ingredient
FR2776659B1 (fr) Nouveaux composes heteroethynylenes et compositions pharmaceutiques et cosmetiques les contenant
FR2791980B1 (fr) Pyrido-thieno-diazepines, leur procede de preparation, et les compositions pharmaceutiques les contenant
FR2807043B1 (fr) Composition pharmaceutique contenant des oligosaccharides, les nouveaux oligosaccharides et leur preparation

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse